Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
09/2007
09/13/2007WO2007005222A3 Cyanine dyes and methods of use in biological applications
09/13/2007WO2006101584A3 Cellulases, nucleic acids encoding them and methods for making and using them
09/13/2007WO2006071255A3 Bacterial replication systems and methods
09/13/2007WO2006071241A3 Compositions for use in identification of bacteria
09/13/2007US20070214521 Role of microRNA in plant salt tolerance
09/13/2007US20070214520 wound closure or coverage systems, comprising employing the recombinant spider silk protein; artificial cartilage, tendon materials, automotive parts or parts used in the aircraft construction, which comprise the protein
09/13/2007US20070214517 Sequence-determined DNA fragments and corresponding polypeptides encoded thereby
09/13/2007US20070214515 Polynucleotide encoding a maize herbicide resistance gene and methods for use
09/13/2007US20070213521 siRNA targeting cell division cycle 25 (CDC25C)
09/13/2007US20070213520 siRNA targeting calcium/calmodulin dependent protein kinase IV (CAMK4)
09/13/2007US20070213519 Building Block Forming A C=C Double Bond Upon Reaction
09/13/2007US20070213518 polypeptide having lipolytic activity; used as detergent enzymes to remove lipid or fatty stains from clothes and other textiles; exhibit improved performance
09/13/2007US20070213293 Rnai therapeutic for respiratory virus infection
09/13/2007US20070213288 Adenoviral Vector Capable of Infecting Tumor Cells and Eliminating the Function of STAT3
09/13/2007US20070213286 Inhibitors of dynein or lissencephaly 1, and methods of using same for treatment of neuronal disorders
09/13/2007US20070213285 Methods and compositions for cancer therapy
09/13/2007US20070213284 Method of selecting targets for gene silencing by RNA interference
09/13/2007US20070213269 Zinc finger binding domains for tnn
09/13/2007US20070213268 inhibiting angiogenesis in tissues expressing a endocrine gland-derived vascular endothelial growth factor(EG-VEGF) polypeptide, comprising contacting the tissue with an antagonist antibody of the EG-VEGF polypeptide or an antigen binding fragment; regulating cellular proliferation and chemotaxis
09/13/2007US20070213267 Peptides and Calcium Regulation in Mammalian Cells
09/13/2007US20070213256 Novel genes and proteins encoded thereby
09/13/2007US20070213255 Novel Hyaluronan-Binding Proteins and Encoding Genes
09/13/2007US20070212788 Methods for detecting modulators of cytokine receptor zalpha11
09/13/2007US20070212757 Expression System for the B Subunit of Cholera Toxin
09/13/2007US20070212755 Novel Sequence for Improving Expression of Nucleic Acid
09/13/2007US20070212753 Altered antibodies and their preparation
09/13/2007US20070212735 Using maytansinoid conjugated monoclonal antibody to treat cell proliferative disorders
09/13/2007US20070212728 32263, a novel human biotin enzyme and uses thereof
09/13/2007US20070212723 Human sodium channel isoforms
09/13/2007US20070212716 Nezara viridula Ecdysone Receptor
09/13/2007US20070212711 P1-34 Expression Units
09/13/2007US20070212710 Competitive hybridization of dna probes and method of using the same
09/13/2007US20070212709 Non-nucleosidic linker linking xanthene donor to 4,7-dichlororhodamine acceptor;
09/13/2007US20070212707 Cell cycle markers
09/13/2007US20070212706 Novel alkaline proteases and detergents and cleaners comprising these novel alkaline proteases
09/13/2007US20070212705 Pseudomonas aeruginosa l-d carboxypeptidase a, expression and activity
09/13/2007US20070212704 Compositions, methods, and kits for amplifying nucleic acids
09/13/2007US20070212697 For analysis of ligated RNA; employed in methods for labeling RNA by contacting a sample containing RNA with an enzyme having an RNA ligation activity in the presence of the labeled nucleotide composition
09/13/2007US20070212695 Compositions, methods, and kits for selective amplification of nucleic acids
09/13/2007US20070212694 Polymorphisms In The Nod2/Card15 Gene
09/13/2007US20070212693 Factor reca from bacillus licheniformis and reca-inactivated safety stems used for biotechnological production
09/13/2007US20070212692 Generation Of Recombinant Genes In Prokaryotic Cells By Using Two Extrachromosomal Elements
09/13/2007US20070212691 Cytolethal Distending Toxins and Detection of Campylobacter Bacteria Using the Same as a Target
09/13/2007US20070212675 Flap Endonuclease (Fen1) Regulatory Sequences And Uses Thereof
09/13/2007US20070212390 Protease-resistant forms of VEGF-D, method of making and method of use
09/13/2007US20070212378 Methods And Compositions For Mycoplasma Pneumoniae Exotoxins
09/13/2007US20070212373 Lawsonia Intracellularis 26 Kd Subunit Vaccine
09/13/2007US20070212365 recombinantly produced polypeptide; contacting a vascular cell with polypeptide for inhibiting angiogeneisis
09/13/2007US20070212363 Immunoglobulins with Potent and Broad Antiviral Activity
09/13/2007US20070212355 GLP-2 Mimetibodies, Polypeptides, Compositions, Methods and Uses
09/13/2007US20070212341 Method for Preparing Active Kinases Containing Ph Domains
09/13/2007US20070212311 Recombinant Alkalinizing Bacteria
09/13/2007US20070212301 Monkey Immunoglobulin Sequences
09/13/2007US20070212299 A gene (designated 161P2F10B) and its encoded protein which exhibits tissue specific expression in normal adult tissue and is aberrantly expressed in the cancers; medical diagnostis;, prognosis, prophylactis and/or gene therapy; tissue-target therapy; used to elicit a humoral or cellular immune response
09/13/2007CA2644588A1 Truncated proteins as cancer markers
09/13/2007CA2644262A1 Antisense antiviral compound and method for treating arenavirus infection
09/13/2007CA2643085A1 Buffers for detection of mrna separated in a microfluidic device
09/13/2007CA2638844A1 Microrna expression profile associated with pancreatic cancer
09/12/2007EP1832663A2 Uses of DNA-PK
09/12/2007EP1832297A1 Anticoagulant agents useful in treatment of thrombosis
09/12/2007EP1831403A2 Genetic markers of schizophrenia
09/12/2007EP1831401A2 Methods, compositions, and kits for forming self-complementary polynucleotides
09/12/2007EP1831385A2 Enzymes for starch processing
09/12/2007EP1831384A2 Polypeptides having glucoamylase activity and polynucleotides encoding same
09/12/2007EP1831238A2 Fluorous oligonucleotide reagents and affinity purification of oligonucleotides
09/12/2007EP1830867A2 Irreversibly-inactivated pepsinogen fragment and pharmaceutical compositions comprising this fragment for detecting, preventing, and treating hiv
09/12/2007EP1581657A4 Methods for rapid identification of pathogens in humans and animals
09/12/2007EP1488236A4 Arrays of microparticles and methods of preparation thereof
09/12/2007EP1373570B1 Improved in vitro synthesis system
09/12/2007EP1224266B1 Lysosomal targeting pathway enzymes
09/12/2007EP1086251B1 Compounds and methods for detecting biomolecules
09/12/2007CN101035901A Addition of transgenes into adenoviral vectors
09/12/2007CN101035900A Monocot AHASS sequences and methods of use
09/12/2007CN101035807A Diagnosis and treatment of SIGLEC-6 associated diseases
09/12/2007CN101035800A Substituted azaporphyrins as fluorescence labels
09/12/2007CN101032508A Purpose of miRNA-145
09/12/2007CN100336905C Wheat fertility recovery gene molecular mark and its obtaining method
09/12/2007CN100336904C Pathogen from rice, chemically inducible promoter and their use
09/12/2007CN100336823C Specific chicken CpG ODN and its application
09/11/2007US7268275 tcdB2 protein from Photorhabdus luminescens W-14
09/11/2007US7268227 Posh nucleic acids, polypeptides and related methods
09/11/2007US7268225 Selected nucleotide sequences isolated from pathogenic strains of haemophilus influenzae
09/11/2007US7268224 Human glucocorticoid receptor 1A promoter and splice variants
09/11/2007US7268223 An antagonists, or agonists, producing antibodies, used as immunotherapy treating allergy, acquired immune deficiency syndrome, autoimmune diabetes, thyroiditis
09/11/2007US7268222 For use in therapeutic, diagnostic, and pharmacogenomic applications
09/11/2007US7268221 Alpha(1,6)-linked glucose oligosaccharide hydrolyzing enzyme polynucleotides and polypeptides and methods of use thereof
09/11/2007US7268215 Bioluminescent protein for use as tool in detection of monovalent cations derived from symplectoteuthis oualaniensis
09/11/2007US7268207 Nucleotide sequences coding polypeptide for use in the treatment of cancer
09/11/2007US7268121 Suppression of nuclear factor-κB dependent processes using oligonucleotides
09/11/2007US7268116 Methods and compositions for producing secreted trimeric receptor analogs and biologically active fusion proteins
09/11/2007US7267976 Suitable for use in the manufacture of microbial oils enriched in omega fatty acids in oleaginous yeast (e.g., Yarrowia lipolytica)
09/11/2007US7267972 Nucleic acid which codes glycerol dehydratase
09/11/2007US7267969 Thermostable omega-transaminases
09/11/2007US7267965 Providing at least one Stabilizing Anti-Repression sequence to a nucleic acid encoding a protein enhances production (yield) of the protein by a host cell increases the proportion of host cells with acceptable expression levels, and/or increases stability of a gene expression level.
09/11/2007US7267964 Nucleotide sequences coding polypeptide for use as insecticide
09/11/2007US7267956 Nucleic acid sequences for detecting the presence of nucleic acids, particularly mRNA, encoding human prostate-associated genetic markers encoding prostate-specific antigen, prostate specific membrane antigen or human kallikrein 2
09/11/2007US7267954 Methods for the detection of variant cayman ataxia nucleic acids
09/11/2007US7267952 Method of extracting virus genes and extraction apparatus
09/11/2007US7267950 Rapid extraction of RNA from cells and tissues
09/11/2007US7267946 Collecting tissue; determining amount of mitochondrial DNA damage in tissue; comparing the amount of mitochondrial DNA damage in tissue of interest to the amount of mitochondrial DNA damage in tissue of interest from a control